NCT07140237View on ClinicalTrials.gov

The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Healthy Adult Male
Interventions
DRUG

Oxytocin lower does (24IU)

Oxytocin (24IU) will be administered as a lingual spray (6, 0.1puffs (4IU per puff) of spray on and under the tongue)

DRUG

Oxytocin higher does (48IU)

Oxytocin (48IU) will be administered as a lingual spray (6, 0.1ml sprays (8IU per puff) on and under the tongue)

DRUG

Atosiban

150ug atosiban administered by lingual sprays (6, 0.1ml sprays on and under the tongue)

DRUG

Placebo

Placebo administered as a lingual spray (6, 0.1puffs (4IU per puff) of spray on and under the tongue). Placebo has the same composition of 0.9% saline and glycerol as for oxytocin and the atosiban interventions.

Trial Locations (1)

Unknown

RECRUITING

School of Life science and Technology, University of Electronic Science and Technology of China, Chengdu

All Listed Sponsors
lead

University of Electronic Science and Technology of China

OTHER